The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Evanthia Diamanti-Kandarakis

Endocrine Section

First Department of Medicine

University of Athens Medical School

Mikras Asias 75

Greece

[email]@otenet.gr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Endocrine Section, First Department of Medicine, University of Athens Medical School, Mikras Asias 75, Greece. 2009 - 2011
  • Third Department of Medicine, Endocrine Unit, Medical School University of Athens, Sotiria General Hospital, Greece. 2001 - 2010
  • University of Athens Medical School, Mikras Asias 75, Goudi 115-27, Athens, Greece. 2003 - 2008
  • Laiko Hospital, Medical School, University of Athens, Endocrine Section, Greece. 2005 - 2007
  • National & Kapodistrian University of Athens, Greece. 2006

References

  1. Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome. Diamanti-Kandarakis, E., Livadas, S., Katsikis, I., Piperi, C., Aimilia, M., Papavassiliou, A.G., Panidis, D. J. Bone Miner. Metab. (2011) [Pubmed]
  2. Metformin in polycystic ovary syndrome. Diamanti-Kandarakis, E., Economou, F., Palimeri, S., Christakou, C. Ann. N. Y. Acad. Sci. (2010) [Pubmed]
  3. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Diamanti-Kandarakis, E., Christakou, C.D., Kandaraki, E., Economou, F.N. Eur. J. Endocrinol. (2010) [Pubmed]
  4. PCOS in adolescents. Diamanti-Kandarakis, E. Best. Pract. Res. Clin. Obstet. Gynaecol (2010) [Pubmed]
  5. Androgens associated with advanced glycation end-products in postmenopausal women. Diamanti-Kandarakis, E., Lambrinoudaki, I., Economou, F., Christou, M., Piperi, C., Papavassiliou, A.G., Creatsas, G. Menopause (2010) [Pubmed]
  6. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome. Diamanti-Kandarakis, E., Kandaraki, E., Christakou, C., Panidis, D. Obes. Rev (2009) [Pubmed]
  7. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy. Diamanti-Kandarakis, E., Economou, F.N., Livadas, S., Tantalaki, E., Piperi, C., Papavassiliou, A.G., Panidis, D. Kidney Blood Press. Res. (2009) [Pubmed]
  8. The acute effect of Orlistat on dietary glycotoxins in diabetics and healthy women. Diamanti-Kandarakis, E., Piperi, C., Alexandraki, K.I., Papailiou, J., Ekonomou, F., Koulouri, E., Kandarakis, H., Creatsas, G. Minerva Endocrinol. (2009) [Pubmed]
  9. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Piouka, A., Livadas, S., Piperi, C., Katsikis, I., Papavassiliou, A.G., Panidis, D. Eur. J. Endocrinol. (2009) [Pubmed]
  10. Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome. Diamanti-Kandarakis, E., Livadas, S., Kandarakis, S.A., Papassotiriou, I., Margeli, A. J. Endocrinol. Invest. (2008) [Pubmed]
  11. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Diamanti-Kandarakis, E. Expert. Rev. Mol. Med (2008) [Pubmed]
  12. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Diamanti-Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A.G., Panidis, D. Clin. Endocrinol. (Oxf) (2008) [Pubmed]
  13. Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). Diamanti-Kandarakis, E., Argyrakopoulou, G., Economou, F., Kandaraki, E., Koutsilieris, M. J. Steroid Biochem. Mol. Biol. (2008) [Pubmed]
  14. Does polycystic ovary syndrome start in childhood? Diamanti-Kandarakis, E., Christakou, C., Palioura, E., Kandaraki, E., Livadas, S. Pediatr. Endocrinol. Rev (2008) [Pubmed]
  15. Brown tumor of the fibula: unusual presentation of an uncommon manifestation. Report of a case and review of the literature. Diamanti-Kandarakis, E., Livadas, S., Tseleni-Balafouta, S., Lyberopoulos, K., Tantalaki, E., Palioura, H., Giannopoulos, A., Kostakis, A. Endocrine (2007) [Pubmed]
  16. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Diamanti-Kandarakis, E., Piperi, C., Patsouris, E., Korkolopoulou, P., Panidis, D., Pawelczyk, L., Papavassiliou, A.G., Duleba, A.J. Histochem. Cell Biol. (2007) [Pubmed]
  17. Role of obesity and adiposity in polycystic ovary syndrome. Diamanti-Kandarakis, E. Int. J. Obes. (Lond) (2007) [Pubmed]
  18. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Diamanti-Kandarakis, E., Christakou, C., Kandarakis, H. Minerva Endocrinol. (2007) [Pubmed]
  19. Pathophysiology and types of dyslipidemia in PCOS. Diamanti-Kandarakis, E., Papavassiliou, A.G., Kandarakis, S.A., Chrousos, G.P. Trends Endocrinol. Metab. (2007) [Pubmed]
  20. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Alexandraki, K., Piperi, C., Aessopos, A., Paterakis, T., Katsikis, I., Panidis, D. Metab. Clin. Exp. (2007) [Pubmed]
  21. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Katsikis, I., Piperi, C., Alexandraki, K., Panidis, D. Clin. Endocrinol. (Oxf) (2007) [Pubmed]
  22. Metabolic syndrome: a contemporary fuel excess syndrome and its specific impact in women. Diamanti-Kandarakis, E., Argyrakopoulou, G. Ann. Endocrinol. (Paris) (2007) [Pubmed]
  23. Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?. Diamanti-Kandarakis, E., Christakou, C.D., Kandaraki, E., Alexandraki, K.I. Hormones. (Athens) (2007) [Pubmed]
  24. Stress in women: metabolic syndrome and polycystic ovary syndrome. Diamanti-Kandarakis, E., Economou, F. Ann. N. Y. Acad. Sci. (2006) [Pubmed]
  25. Indices of low-grade inflammation in polycystic ovary syndrome. Diamanti-Kandarakis, E., Paterakis, T., Kandarakis, H.A. Ann. N. Y. Acad. Sci. (2006) [Pubmed]
  26. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Diamanti-Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N., Kreatsas, G., Panidis, D. Hum. Reprod. (2006) [Pubmed]
  27. Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Piperi, C., Alexandraki, K., Katsilambros, N., Kouroupi, E., Papailiou, J., Lazaridis, S., Koulouri, E., Kandarakis, H.A., Douzinas, E.E., Creatsas, G., Kalofoutis, A. Metab. Clin. Exp. (2006) [Pubmed]
  28. Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS. Diamanti-Kandarakis, E., Papailiou, J., Palimeri, S. Pediatr. Endocrinol. Rev (2006) [Pubmed]
  29. Polycystic ovary syndrome: the influence of environmental and genetic factors. Diamanti-Kandarakis, E., Piperi, C., Spina, J., Argyrakopoulou, G., Papanastasiou, L., Bergiele, A., Panidis, D. Hormones. (Athens) (2006) [Pubmed]
  30. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Diamanti-Kandarakis, E., Papavassiliou, A.G. Trends. Mol. Med (2006) [Pubmed]
  31. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A., Katsikis, I., Paterakis, T., Lekakis, J., Panidis, D. Eur. J. Clin. Invest. (2006) [Pubmed]
  32. Update on polycystic ovary syndrome. Diamanti-Kandarakis, E., Panidis, D. Women's. Health. (london,. England) (2006) [Pubmed]
  33. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Piperi, C., Kalofoutis, A., Creatsas, G. Clin. Endocrinol. (Oxf) (2005) [Pubmed]
  34. Metformin administration improves endothelial function in women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Alexandraki, K., Protogerou, A., Piperi, C., Papamichael, C., Aessopos, A., Lekakis, J., Mavrikakis, M. Eur. J. Endocrinol. (2005) [Pubmed]
  35. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Diamanti-Kandarakis, E., Piperi, C. Hum. Reprod. Update (2005) [Pubmed]
  36. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era. Diamanti-Kandarakis, E., Konstantinopoulos, P.A., Papailiou, J., Kandarakis, S.A., Andreopoulos, A., Sykiotis, G.P. Sports. Med (2005) [Pubmed]
  37. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. Diamanti-Kandarakis, E., Kouli, C., Alexandraki, K., Spina, G. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  38. Hormone replacement therapy and risk of malignancy. Diamanti-Kandarakis, E. Curr. Opin. Obstet. Gynecol. (2004) [Pubmed]
  39. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Diamanti-Kandarakis, E., Palioniko, G., Alexandraki, K., Bergiele, A., Koutsouba, T., Bartzis, M. Eur. J. Endocrinol. (2004) [Pubmed]
  40. Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance. Diamanti-Kandarakis, E., Alexandraki, K., Bergiele, A., Kandarakis, H., Mastorakos, G., Aessopos, A. J. Endocrinol. Invest. (2004) [Pubmed]
  41. Obesity and gonadal function of women. Diamanti-Kandarakis, E., Kandarakis, H.A. Pediatr. Endocrinol. Rev (2004) [Pubmed]
  42. Hormones in sports: growth hormone abuse. Diamanti-Kandarakis, E., Tsilakis, D., Lazarides, S., Kandarakis, H., Bergele, A. Hormones. (Athens) (2004) [Pubmed]
  43. Primary adrenal lymphoma presented with adrenal insufficiency. Diamanti-Kandarakis, E., Chatzismalis, P., Economou, F., Lazarides, S., Androulaki, A., Kouraklis, G. Hormones. (Athens) (2004) [Pubmed]
  44. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma. Diamanti-Kandarakis, E., Sykiotis, G.P., Papavassiliou, A.G. Cancer (2003) [Pubmed]
  45. Conservative management of gynecologic diseases: insulin sensitizing agents in polycystic ovary syndrome. Diamanti-Kandarakis, E., Kandarakis, H.A. Ann. N. Y. Acad. Sci. (2003) [Pubmed]
  46. The influence of obesity on hyperandrogenism and infertility in the female. Diamanti-Kandarakis, E., Bergiele, A. Obes. Rev (2001) [Pubmed]
 
WikiGenes - Universities